Both compounds have attracted clinical interest due to their roles in energy metabolism, cardiovascular health, and potential therapeutic applications in various conditions characterised by mitochondrial dysfunction or energy deficiency

What's Confirmed for 2026 Coverage depends on employer opt-in: The standard Express Scripts National Preferred Formulary does not include Wegovy for weight loss, but employer plans can opt into coverage [8] $200/month cap expanding: The Evernorth cost-cap program launched in May 2025 is being offered to more employer groups [6] Medicare still excluded: No change expectedfederal statute continues to block weight loss drugs in Part D [9] What This Means for You Check your specific plan: Coverage depends on your employer's benefit designdon't assume During open enrollment: Ask HR if your employer is adding the $200/month cap or GLP-1 coverage Self-funded employers: Large employers can add or modify GLP-1 coverage at renewal Consider alternatives: If you have Type 2 diabetes, Ozempic (same active ingredient as Wegovy) may be covered for diabetes CALL YOUR INSURANCE Verify Your Specific Coverage Verify Your Specific Coverage Even though it takes a little more time, we recommend calling so you can speak with a person who may have more information than the online directory or PDF formulary listing

The amount of weight loss varies from person to person, but clinical trials have shown that people taking Semaglutide can lose an average of 12+% of their body weight
Using B12 injections outside clinical necessity exposes patients to unnecessary risks without proven benefit
They dont teach you how to eat when you stop taking them
While our meta-analysis demonstrated robust protective associations between GLP-1R activation and psychiatric conditions such as schizophrenia and anxiety disorders, sensitivity analyses revealed broader CIs that occasionally crossed the null